Gilles Edan

1977–2025 年に発表

101
論文数
27,047
被引用数
61
h 指数
88
i10 指数

被引用数

Gilles Edan の年別被引用数1973 年: 被引用 1 件1980 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 4 件1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 2 件1995 年: 被引用 2 件1996 年: 被引用 4 件1997 年: 被引用 7 件1998 年: 被引用 5 件1999 年: 被引用 2 件2000 年: 被引用 5 件2001 年: 被引用 19 件2002 年: 被引用 77 件2003 年: 被引用 70 件2004 年: 被引用 85 件2005 年: 被引用 141 件2006 年: 被引用 150 件2007 年: 被引用 205 件2008 年: 被引用 263 件2009 年: 被引用 302 件2010 年: 被引用 292 件2011 年: 被引用 314 件2012 年: 被引用 268 件2013 年: 被引用 276 件2014 年: 被引用 233 件2015 年: 被引用 219 件2016 年: 被引用 189 件2017 年: 被引用 166 件2018 年: 被引用 167 件2019 年: 被引用 607 件2020 年: 被引用 652 件2021 年: 被引用 611 件2022 年: 被引用 542 件2023 年: 被引用 338 件2024 年: 被引用 550 件2025 年: 被引用 276 件2026 年: 被引用 18 件1974〜1979 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,882 件、この内訳の 18.2%イタリア: 引用元論文 880 件、この内訳の 8.5%イギリス: 引用元論文 841 件、この内訳の 8.1%ドイツ: 引用元論文 802 件、この内訳の 7.8%カナダ: 引用元論文 578 件、この内訳の 5.6%フランス: 引用元論文 542 件、この内訳の 5.3%スイス: 引用元論文 436 件、この内訳の 4.2%スペイン: 引用元論文 427 件、この内訳の 4.1%オランダ: 引用元論文 408 件、この内訳の 4%オーストラリア: 引用元論文 317 件、この内訳の 3.1%スウェーデン: 引用元論文 251 件、この内訳の 2.4%中国: 引用元論文 225 件、この内訳の 2.2%
0%18.2%その他 26.5%

分野

  • Medicine79.5%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Neuroscience4.3%
  • Immunology and Microbiology3.5%
  • Computer Science2.5%
  • Engineering0.6%
  • その他2.1%

トピック

  • Multiple Sclerosis Research Studies23.7%
  • Peripheral Neuropathies and Disorders7.1%
  • Polyomavirus and related diseases2.7%
  • Systemic Lupus Erythematosus Research2.7%
  • Neuroinflammation and Neurodegeneration Mechanisms2.2%
  • Rheumatoid Arthritis Research and Therapies1.9%
  • その他59.7%

共著者

全論文

検索で開く
  1. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch ほか 228 名 - The Lancet 2018 被引用: 925

  2. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

    著者: , , , , , , , , , , , , , - Annals of Neurology 2005 被引用: 4,989

  3. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

    著者: , , , , , , , , , , , , , , , - Annals of Neurology 2001 被引用: 6,953

  4. Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Tomas-Fernandez, Hélène Urien, Isabelle Bloch, Sergi Valverde, Mariano Cabezas, Francisco Javier Vera-Olmos, Norberto Malpica, Charles R.G. Guttmann, Sandra Vukusic, Gilles Edan, Michel Dojat, Martin Styner, Simon K. Warfield, François Cotton, Christian Barillot - Scientific Reports 2018 被引用: 282

  5. Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge dataset

    著者: , , , , , , , , , , , , , , - NeuroImage 2021 被引用: 101

  6. Multiple Sclerosis Severity Score

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mónica Marta, Isabel Cristina Gonçalves Leite, Bénédicte Dubois, Justin P. Rubio, Helmut Butzkueven, Trevor J. Kilpatrick, Marcin P. Mycko, Krzysztof Selmaj, M. E. Rio, Márcia Christel Sá, Giuseppe Salemi, G Savettieri, Jan Hillert, D. A. S. Compston - Neurology 2005 被引用: 955

  7. Epidemiology of multiple sclerosis

    著者: , , , - Revue Neurologique 2015 被引用: 469

  8. Natural History of Multiple Sclerosis with Childhood Onset

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 591

  9. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , B. Stankoff, Sandra Vukusic, Romain Marignier, Marc Debouverie, Gilles Edan, Jonathan Ciron, Aurélie Ruet, Nicolas Collongues, Catherine Lubetzki, P. Vermersch, Pierre Labauge, Gilles Defer, Mikaël Cohen, Agnès Fromont, Sandrine Wiertlewsky, Eric Berger, P. Clavelou, Bertrand Audoin, C. Giannesini, Olivier Gout, Éric Thouvenot, O. Heinzlef, A. Al-Khedr, Bertrand Bourre, O. Casez, P. Cabré, Alexis Montcuquet, Alain Créange, Jean‐Philippe Camdessanché, Justine Faure, Aude Maurousset, I. Patry, Karolina Hankiewicz, Corinne Pottier, Nicolas Maubeuge, Céline Labeyrie, Chantal Nifle, Roxana Améli, René Anxionnat, Arnaud Attyé, Élise Bannier, C. Barillot, D. Ben Salem, M.-P. Boncoeur-Martel, Fabrice Bonneville, Claire Boutet, Jean‐Christophe Brisset, Frédéric Cervenanski, B. Claise, Olivier Commowick, J.-M. Constans, Pascal Dardel, H. Desal, Vincent Dousset, F. Durand-Dubief, J.-C. Ferre, Emmanuel Gérardin, Tristan Glattard, Sylvie Grand, Thomas Grenier, Rémy Guillevin, Charles R.G. Guttmann, Alexandre Krainik, S. Kremer, Stéphanie Lion, Nicolas Menjot de Champfleur, Lydiane Mondot, Olivier Outteryck, N. Pyatigorskaya, Jean‐Pierre Pruvo ほか 9 名 - Diagnostic and Interventional Imaging 2020 被引用: 94

  10. Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

    著者: , , , , , , , , , , , , , , , , - JAMA Neurology 2014 被引用: 512

  11. Evidence for a two-stage disability progression in multiple sclerosis

    著者: , , , , , , - Brain 2010 被引用: 587

  12. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Brum, Maria Fernanda Mendes, Ricardo N. Alonso, Richard S. Nicholas, Johana Bauer, Aníbal Sebastián Chertcoff, Anna Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet Peeters - Neurology 2021 被引用: 238

  13. High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olivier Casez, Bertrand Bourre, Philippe Cabre, Abir Wahab, Laurent Magy, Jean‐Philippe Camdessanché, Inès Doghri, Solène Moulin, Haifa Ben-Nasr, Céline Labeyrie, Karolina Hankiewicz, Jean‐Philippe Neau, Corinne Pottier, Chantal Nifle, Nicolas Collongues, Anne Kerbrat, OFSEP Investigators, François Cotton, Pascal Douek, Francis Guillememin, Alexandre Pachot, Javier Olaiz, Claire Rigaud-Bully, Romain Marignier, Marc Debouverie, Catherine Lubetzki, Mikaël Cohen, Agnès Fromont, Sandrine Wiertlewsky, Bertrand Audoin, C. Giannesini, Olivier Gout, Alexis Montcuquet, Serge Bakchine, Aude Maurousset, Nicolas Maubeuge - JAMA Neurology 2024 被引用: 47

  14. Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2021 被引用: 89

  15. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisabetta Cartechini, Cavit Boz, Jeannette Lechner‐Scott, Pierre Clavelou, Bruno Stankoff, Julie Prévost, Ludwig Kappos, Jean Pelletier, Vahid Shaygannejad, Bassem Yamout, Samia J. Khoury, Oliver Gerlach, Daniele Spitaleri, Vincent van Pesch, Olivier Gout, Recai Türkoğlu, Olivier Heinzlef, Éric Thouvenot, Pamela McCombe, Aysun Soysal, Bertrand Bourre, Mark Slee, Tamara Castillo‐Triviño, Serge Bakchine, Radek Ampapa, Ernest Butler, Abir Wahab, Richard Macdonell, Eduardo Agüera, Philippe Cabre, Nasr Haifa Ben, Anneke van der Walt, Guy Laureys, Liesbeth Van Hijfte, Cristina Ramo‐Tello, Nicolas Maubeuge, Suzanne Hodgkinson, José Luis Sánchez-Menoyo, Michael Barnett, Céline Labeyrie, Steve Vucic, Youssef Sidhom, Riadh Gouider, Tünde Csépány, Javier Sotoca, Koen de Gans, Abdullah Al‐Asmi, Yára Dadalti Fragoso, Sandra Vukusic, Helmut Butzkueven, Tomáš Kalinčík, on behalf of MSBase and OFSEP - Neurology 2022 被引用: 46

  16. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

    著者: , , , , , , , , , , , , , , , , , - Multiple Sclerosis Journal 2016 被引用: 287

  17. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olga Ciccarelli, Seth A. Smith, Constantina A. Treaba, Caterina Mainero, Jennifer Lefeuvre, Daniel S. Reich, Govind Nair, Timothy M. Shepherd, Erik Charlson, Yasuhiko Tachibana, Masaaki Hori, Kouhei Kamiya, Lydia Chougar, Sridar Narayanan, Julien Cohen‐Adad - Brain 2019 被引用: 118

  18. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ingrid van der Mei, Nupur Nag, R Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Guimarães Brum, María Fernanda Mendes, Ricardo Alonso, Richard Nicholas, Johana Bauer, Aníbal Chertcoff, Ana Zabalza, Georgina Arrambide, Alexander Fidao, Gıancarlo Comı, Liesbet M. Peeters - 2021 被引用: 157

  19. Aggressive multiple sclerosis (1): Towards a definition of the phenotype

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ho-Jin Kim, Eva Havrdová, Roland Liblau, Jan Lycke, Xavier Montalbán, Paolo A. Muraro, Stephen C. Reingold, Klaus Schmierer, Finn Sellebjerg, Per Soelberg Sørensen, Alessandra Solari, Maria Pia Sormani, Alan J. Thompson, Bruce D. Trapp, Helen Tremlett, María Trojano, Carmen Tur, Antonio Uccelli, Vincent Van Pesch, Emmanuelle Waubant - Multiple Sclerosis Journal 2020 被引用: 79

  20. Updated Results of the COVID-19 in MS Global Data Sharing Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda Magyari, Ricardo Alonso, Richard Nicholas, Aníbal Chertcoff, Ana Zabalza de Torres, Georgina Arrambide, Nupur Nag, A. Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rogério Melo Rodrigues, Vesna Prčkovska, Gıancarlo Comı, Liesbet M. Peeters - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 53

  21. Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study

    著者: , , , , , , , , , , , , - Multiple Sclerosis Journal 2023 被引用: 49

  22. Body mass index as a predictor of MS activity and progression among participants in BENEFIT

    著者: , , , , , , , , , , , , - Multiple Sclerosis Journal 2022 被引用: 34

  23. Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis

    著者: , , , , , , , , - Journal of Neurology 2022 被引用: 19

  24. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bertrand Audoin, Adil Maarouf, Nicolas Collongues, de Sèze, Gilles Edan, Julien Cohen‐Adad - Brain 2020 被引用: 62